1. Sugen Incorporated (101 from 157 patents)

2. Other (6 from 831,952 patents)

3. Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (6 from 880 patents)

4. Glycomed, Inc. (6 from 56 patents)

5. Pharmacia & Upjohn Company (4 from 521 patents)

6. Agouron Pharmaceuticals, Inc. (2 from 173 patents)

7. Cardax Pharmaceuticals, Inc. (2 from 12 patents)

8. Yissum Research Development (2 from 4 patents)

9. University of California (1 from 15,294 patents)

10. New York University (1 from 1,616 patents)

1. 7582756 - 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors

2. 7572924 - Pyrrole substituted 2-indolinone protein kinase inhibitors

3. 7435861 - Methods for synthesis of carotenoids, including analogs, derivatives, and synthetic and biological intermediates

4. 7256189 - 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors

5. 7247752 - Methods for the synthesis of astaxanthin

6. 7217737 - Method and compositions for inhibiting cell proliferative disorders

7. 7214700 - (2-Oxindol-3-ylidenyl) acetic acid derivatives and their use as protein kinase inhibitors

8. 7202265 - Indolinone combinatorial libraries and related products and methods for the treatment of disease

9. 7189721 - Bicyclic protein kinase inhibitors

10. 7179910 - 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors

11. 7157577 - 5-sulfonamido-substituted indolinone compounds as protein kinase inhibitors

12. 7125905 - Pyrrole substituted 2-indolinone protein kinase inhibitors

13. 7119090 - Pyrrole substituted 2-indolinone protein kinase inhibitors

14. 7105562 - Geometrically restricted 3-cyclopentylidene-1,3-dihydroindol-2-ones as potent protein tyrosine kinase inhibitors

15. 7071332 - Indolinone derivatives as protein kinase/phosphatase inhibitors